METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST

The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LAVALLEE, Theresa, MCDANIEL, Lee Davis, KITCH, Lacey
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec une polythérapie avec un agoniste CD40 et un ou plusieurs médicaments de chimiothérapie.